Atomoxetine Treatment Outcomes in Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder: Results From a Post Hoc, Pooled Analysis

• Published in: Clinical therapeutics Vol. 34; no. 2; pp. 363 - 373
• Main Authors: Adler, Lenard A., Wilens, Timothy, Zhang, Shuyu, Dittmann, Ralf W., D'Souza, Deborah N., Schuh, Leslie, Durell, Todd M.
• Format: Journal Article
• Language: English
• Published: Bridgewater, NJ EM Inc USA 01.02.2012; Elsevier; Elsevier Limited
• Subjects: ADHD; adolescence; Adolescent; Adrenergic Uptake Inhibitors - therapeutic use; atomoxetine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity - drug therapy; Attention Deficit Hyperactivity Disorder; Biological and medical sciences; Child; Children & youth; Female; Humans; Hyperactivity; Internal Medicine; Male; Medical Education; Medical sciences; Pharmaceutical industry; Pharmacology. Drug treatments; Propylamines - adverse effects; Propylamines - therapeutic use; Randomized Controlled Trials as Topic; Studies; Teenagers; Treatment Outcome; Young Adult; young adulthood; adolescence; ADHD; young adulthood; atomoxetine; Human; Prognosis; Psychotropic; Catecholamine; Reuptake inhibitor; Treatment; Atomoxetine; Adolescent; Young adult; Neurotransmitter; Norepinephrine; Attention disorder with hyperactivity

Many children with attention-deficit/hyperactivity disorder (ADHD) continue to experience this disorder as adults, which may, in part, be due to the discontinuity of health care that often occurs during the transition period between late adolescence and young adulthood. Although atomoxetine is repor...